AURA logo

Aura Biosciences, Inc. (AURA)

Profile

Full Name

Aura Biosciences, Inc.

Ticker

NASDAQ: AURA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 29, 2021

Indexes

Not included

Website

https://www.aurabiosciences.com

Employees

106

Key Details

Price

$6.18(-6.93%)

Market cap

$383.90M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$1.75(+9.33% YoY)

PE ratio

-

Next earnings date

Nov 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $6.18
    AURA price is $6.18

    30-Day Relative Volume

    1.25
    AURA 30-day relative volume is 1.25

    Price Performance

    Price Most recent change

    -6.93%
    AURA price was down -6.93% on Sep 12, 2025

    Price YTD change

    -24.82%
    AURA price is down -24.82% since January 1st

    Price 1-year change

    -36.87%
    AURA price is down -36.87% year-on-year

    Price 3-year change

    -63.86%
    AURA price is down -63.86% over the past 3 years

    Price Range

    Price All-time high

    $26.16
    AURA price is currently -76.38% below its historical high of $26.16

    Price 3-year low

    $4.34
    AURA price is currently +42.23% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $383.90M
    AURA market capitalization is $383.90 million

    Market cap 3-year change

    -23.31%
    AURA market capitalization is down -23.31% over the past 3 years

    Market cap All-time high

    $707.11M
    AURA market capitalization is currently -45.71% below its historical high of $707.11 million

    Market cap sector rank

    60.13%
    AURA market capitalization is higher than 60.13% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +25.23%
    AURA shares outstanding is up +25.23% year-on-year

    Shares Outstanding 3-Year Change

    +112.2%
    AURA shares outstanding is up +112.2% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.94
    AURA beta is 0.94

    200-day SMA

    $6.92
    AURA price is currently -10.75% below its 200-day simple moving average

    50-day SMA

    $6.64
    AURA price is currently -6.98% below its 50-day simple moving average

    RSI

    40.06
    AURA 14-day relative strength index is 40.06

    Volume

    1.25
    AURA 30-day relative volume is 1.25

    ATR

    $0.32
    AURA average true range is $0.32

    10-day Historical Volatility

    43.26%
    AURA 10-day historical volatility is 43.26%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    AURA annual revenue is $0.00

    Revenue Analysts estimate

    -
    AURA annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    AURA annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.75%
    AURA annual revenue is higher than 28.75% of companies in Healthcare sector

    EPS

    EPS

    -$1.75
    AURA annual earnings per share is -$1.75

    EPS Analysts estimate

    -$2.05
    AURA annual earnings per share is currently -14.70% lower than the consensus analysts' forecast

    EPS 1-year change

    +9.33%
    AURA annual earnings per share is up +9.33% year-on-year

    EPS Sector rank

    39.06%
    AURA annual earnings per share is higher than 39.06% of companies in Healthcare sector

    Profit

    Gross profit

    -$1.22M
    AURA annual gross profit is -$1.22 million

    Gross margin

    -
    AURA annual gross profit margin value is unknown

    Operating profit

    -$96.12M
    AURA annual operating income is -$96.12 million

    Operating margin

    -
    AURA annual operating profit margin value is unknown

    Net income

    -$86.92M
    AURA annual net profit is -$86.92 million

    Net margin

    -
    AURA annual net profit margin value is unknown

    Expenses

    Total expenses

    $96.12M
    AURA annual total expenses is $96.12 million

    Operating expenses

    $96.12M
    AURA annual total operating expenses is $96.12 million

    Cost of goods sold

    $1.22M
    AURA annual cost of goods sold is $1.22 million

    Selling, general & administrative expenses

    $22.81M
    AURA annual SGA is $22.81 million

    Depreciation and amortization

    $1.22M
    AURA annual depreciation & amortization is $1.22 million

    Interest expense

    $0.00
    AURA annual interest expense is $0.00

    Income tax

    $112.00K
    AURA annual income tax is $112.00 thousand

    EBIT & EBITDA

    EBIT

    -$96.12M
    AURA annual earnings before interest & taxes is -$96.12 million

    EBITDA

    -$94.89M
    AURA annual EBITDA is -$94.89 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $182.50M
    AURA annual total assets is $182.50 million

    Non current assets

    $21.88M
    AURA annual long term assets is $21.88 million

    Current assets

    $160.62M
    AURA annual total current assets is $160.62 million

    Cash and cash equivalents

    $31.69M
    AURA annual cash & cash equivalents is $31.69 million

    Accounts receivable

    -
    AURA annual accounts receivable value is unknown

    Inventory

    $0.00
    AURA annual inventory is $0.00

    Liabilities

    Total liabilities

    $30.53M
    AURA annual total liabilities is $30.53 million

    Long term liabilities

    $15.62M
    AURA annual total long term liabilities is $15.62 million

    Current liabilities

    $14.91M
    AURA annual total current liabilities is $14.91 million

    Accounts payable

    $2.30M
    AURA annual accounts payable is $2.30 million

    Debt

    Total debt

    $18.77M
    AURA annual total debt is $18.77 million

    Total debt 1-year change

    -4.03%
    AURA annual total debt is down -4.03% year-on-year

    Long term debt

    $15.62M
    AURA annual long term debt is $15.62 million

    Short term debt

    $3.15M
    AURA annual short term debt is $3.15 million

    Equity & Capital

    Shareholders equity

    $151.97M
    AURA annual stockholders equity is $151.97 million

    Book value

    $151.97M
    AURA annual book value is $151.97 million

    Retained earnings

    -$374.23M
    AURA annual retained earnings is -$374.23 million

    Working capital

    $145.71M
    AURA annual working capital is $145.71 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$79.81M
    AURA annual cash flow from operations is -$79.81 million

    Cash from operations 1-year change

    -24.99%
    AURA annual cash flow from operations is down -24.99% year-on-year

    Cash from investing

    $68.82M
    AURA annual cash flow from investing activities is $68.82 million

    Cash from investing 1-year change

    +160.39%
    AURA annual cash flow from investing activities is up +160.39% year-on-year

    Cash from financing

    $1.59M
    AURA annual cash flow from financing activities is $1.59 million

    Cash from financing 1-year change

    -98.36%
    AURA annual cash flow from financing activities is down -98.36% year-on-year

    CAPEX

    CAPEX

    $1.25M
    AURA annual capital expenditures is $1.25 million

    CAPEX 1-year change

    +76.73%
    AURA annual capital expenditures is up +76.73% year-on-year

    Free Cash Flow

    Free cash flow

    -$81.06M
    AURA annual free cash flow is -$81.06 million

    Free cash flow 1-year change

    -25.56%
    AURA annual free cash flow is down -25.56% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    AURA annual gross profit margin value is unknown

    Operating margin

    -
    AURA annual operating profit margin value is unknown

    Net margin

    -
    AURA annual net profit margin value is unknown

    ROA & ROE

    ROA

    -39.73%
    AURA annual return on assets is -39.73%

    ROE

    -46.01%
    AURA annual return on equity is -46.01%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AURA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AURA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.20
    AURA price to book ratio is 2.20

    PB ratio Sector rank

    55.9%
    AURA price to book ratio is higher than 55.9% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    AURA price to sales ratio value is unknown

    PS ratio Sector rank

    -
    AURA price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $224.70M
    AURA enterprise value is $224.70 million

    Enterprise value Sector rank

    56.85%
    AURA enterprise value is higher than 56.85% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -2.09
    AURA EV/EBITDA is -2.09

    EV/EBITDA Sector rank

    36.44%
    AURA EV/EBITDA is higher than 36.44% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    10.77
    AURA annual current ratio is 10.77

    Quick ratio

    10.77
    AURA annual quick ratio is 10.77

    Leverage

    Debt to equity

    0.12
    AURA annual debt to equity ratio is 0.12

    Interest coverage ratio

    -
    AURA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    AURA piotroski f-score value is unknown

    Altman Z-Score

    3.89
    AURA altman z-score is 3.89

    Analyst ratings

    Recent major analysts updates

    Aug 13, 25 HC Wainwright & Co.
    Buy
    May 23, 25 JMP Securities
    Market Outperform
    Mar 26, 25 JMP Securities
    Market Outperform
    Mar 26, 25 Citizens Capital Markets
    Market Outperform
    Mar 25, 25 HC Wainwright & Co.
    Buy
    Mar 24, 25 HC Wainwright & Co.
    Buy
    Dec 5, 24 JMP Securities
    Market Outperform
    Nov 14, 24 HC Wainwright & Co.
    Buy
    Oct 18, 24 Scotiabank
    Sector Outperform
    Oct 18, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with AURA included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Aura Biosciences, Inc.?
    • Does Aura Biosciences, Inc. pay dividends?
    • What sector is Aura Biosciences, Inc. in?
    • What industry is Aura Biosciences, Inc. in?
    • What country is Aura Biosciences, Inc. based in?
    • When did Aura Biosciences, Inc. go public?
    • Is Aura Biosciences, Inc. in the S&P 500?
    • Is Aura Biosciences, Inc. in the NASDAQ 100?
    • Is Aura Biosciences, Inc. in the Dow Jones?
    • When was Aura Biosciences, Inc.'s last earnings report?
    • When does Aura Biosciences, Inc. report earnings?

    What is the ticker symbol for Aura Biosciences, Inc.?

    The ticker symbol for Aura Biosciences, Inc. is NASDAQ:AURA

    Does Aura Biosciences, Inc. pay dividends?

    No, Aura Biosciences, Inc. does not pay dividends

    What sector is Aura Biosciences, Inc. in?

    Aura Biosciences, Inc. is in the Healthcare sector

    What industry is Aura Biosciences, Inc. in?

    Aura Biosciences, Inc. is in the Biotechnology industry

    What country is Aura Biosciences, Inc. based in?

    Aura Biosciences, Inc. is headquartered in United States

    When did Aura Biosciences, Inc. go public?

    Aura Biosciences, Inc.'s initial public offering (IPO) was on October 29, 2021

    Is Aura Biosciences, Inc. in the S&P 500?

    No, Aura Biosciences, Inc. is not included in the S&P 500 index

    Is Aura Biosciences, Inc. in the NASDAQ 100?

    No, Aura Biosciences, Inc. is not included in the NASDAQ 100 index

    Is Aura Biosciences, Inc. in the Dow Jones?

    No, Aura Biosciences, Inc. is not included in the Dow Jones index

    When was Aura Biosciences, Inc.'s last earnings report?

    Aura Biosciences, Inc.'s most recent earnings report was on August 13, 2025

    When does Aura Biosciences, Inc. report earnings?

    The next expected earnings date for Aura Biosciences, Inc. is November 14, 2025
    On this page